045: Molecular determinants of therapy response in metastatic clear cell renal cell cancer

HIPO Investigator:

Prof. Sascha Pahernik

Prof. Holger Sültmann

Prof. Markus Hohenfellner

Prof. Wilfried Roth

Prof. Stefan Fröhling

Prof. Stefan Duensing

Entity: ccRCC


Dieffenbacher S et al.; Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL; Future Sci OA 2018

Dietz S et al.; Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy; Oncotarget 2017


DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok Decline